Stock screenerAll disclosures →
EDGAR →
MAIA
Conviction 44HealthcareScan · Mon, Aug 10, 2026MAIA$1.41-0.70%
ResistanceSupportVol 14Insider buy3
Vol MA14 385.19K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price1.41
Change-0.70%
Gap-2.46%
Rel volume0.59×
Avg volume486.63K
Avg $ vol650.44K
SMA 201.33
SMA 501.36
SMA 2001.46
Price vs 50+3.49%
Price vs 200-3.73%
MA stackmixed
50/200 cross—
Supertrenddown · 1.45
RSI (14)57
MACD hist0.02
MACD crossbull · 4d
Stoch %K / %D79 / 81
ADX (14)19
+DI / −DI24 / 14
RSI divergence—
MACD divergence—
ATR %+5.17%
ADR %5.28%
52w high2.95
52w low0.8710
From 52w high-52.20%
Above 52w low+61.88%
New 52w highNo
SqueezeOff
Bollinger width22.88%
%B0.78
Donchian pos64.71%
Donchian high1.53
Donchian low1.19
AVWAP (52w high)1.54
vs AVWAP high-8.19%
AVWAP (52w low)1.59
vs AVWAP low-11.26%
OBV trendFlat
Chaikin MF (20)-0.18
Today vs 20d0.59×
Avg vol (14d)385.19K
Avg vol (20d)486.63K
Avg $ vol (20d)650.44K
Market cap—
RS 3m (vs SPY)+2.70%
RS 6m (vs SPY)-39.77%
RS line new highNo
Trend template4/8
Technical rank32.5
1 week+6.82%
1 month-2.08%
3 months+6.82%
6 months-28.43%
1 year-4.73%
YTD-11.88%
P/E-3.90
P/B3.14
P/S—
P/FCF—
EPS-0.7000
Div yield—
ROE-80.67%
ROA-63.40%
Debt/Eq0.00
Current5.59
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth3.69%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value87.25M
Revenue0
Net income-6.37M
Gross profit—
Free cash flow—
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNYSE
Shares out60.8M
Employees13
ListedThu, Jul 28, 2022
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction44 / 100
Pattern quality—
Tech rank32.5 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance1.52
Support1.19
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in MAIA
No recent disclosed trades by Congress in MAIA. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in MAIA · 8 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Vitoc Vlad Chief Executive Officer · Common Stock · 2026-06-01 | Buy | 72.7K | $101K | 2026-06-01 | 2026-06-02 |
Smith Stan Director · Common Stock · 2026-06-01 | Buy | 75K | $100K | 2026-06-01 | 2026-06-02 |
Gryaznov Sergei Chief Scientific Officer · Common Stock · 2026-06-01 | Buy | 2K | $3K | 2026-06-01 | 2026-06-02 |
Vitoc Vlad Chief Executive Officer · Common Stock · 2026-06-01 | Other | — | — | 2026-06-01 | 2026-06-02 |
Smith Stan Director · Common Stock · 2026-06-01 | Other | — | — | 2026-06-01 | 2026-06-02 |
Gryaznov Sergei Chief Scientific Officer · Stock Options · 2026-05-29 | Grant | 400K | $0 | 2026-05-29 | 2026-06-01 |
Himmelreich Jeffrey C Head of Finance · Stock Options · 2026-05-29 | Grant | 60K | $0 | 2026-05-29 | 2026-06-01 |
Vitoc Vlad Chief Executive Officer · Stock Options · 2026-05-29 | Grant | 800K | $0 | 2026-05-29 | 2026-06-01 |
Gryaznov Sergei Chief Scientific Officer · Stock Options · 2026-04-10 | Grant | 400K | $0 | 2026-04-10 | 2026-04-14 |
Himmelreich Jeffrey C Head of Finance · Stock Options · 2026-04-10 | Grant | 30K | $0 | 2026-04-10 | 2026-04-14 |
SEC filings
EDGAR filings in MAIA
No recent SEC filings on file for MAIA.
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.